Medipost Co., Ltd. engages in the development and manufacture of stem cell biotechnology products. It operates through the following business divisions: Cord Blood Bank, Stem Cell Therapy, Health Functional Food, Import and Distribution of Natural Cosmetics and Healthcare Services. The Cord Blood Bank division is involved in collecting and storing stem cells from the newborn's umbilical cord. The Stem Cell Therapy division manufactures allogeneic stem cell drug products. The Health Functional Food division offers vitamins and nutritional supplements. The Import and Distribution of Natural Cosmetics division is involved in the sales and marketing of natural cosmetics imported by Pevonia Inc. The Healthcare Services division provides healthcare solutions such as bizcare, insu-care, affiliate, telehealth services and medical devices through web, mobile, and call centers. The company was founded by Yoon-Sun Yang and Won-Il Oh on June 26, 2000 and is headquartered in Seongnam, South Korea.

Yissum is the technology transfer company of The Hebrew University of Jerusalem. Founded in 1964, it is the 3rd company of its kind ever created, and has a rich tradition of innovation and commercialization. Through our efforts to identify and create breakthrough scientific research at Hebrew University, we aspire to advance commercial solutions to the most pressing global challenges facing humanity. (Contact Tamir Huberman) Some of our well-known spin-off companies include Mobileye, Orcam, Collplant, Qlight, and Briefcam. Yissum’s business partners span the globe and include companies such as Novartis, Johnson & Johnson, Merck, Intel, Google, Boston Scientific, ICL and many more. Since its inception, Yissum has registered 10,000+ patents covering 2,800+ inventions; licensed 900 technologies and produced 130+ spin-off companies.

Hox Therapeutics Ltd. is a private company headquartered in Guildford, UK, that develops therapeutics for cancer diseases based on the role of HOX genes.\nThe company says this about itself: HOX Therapeutics is developing innovative, first-in-class and highly targeted cancer therapies. Its scientific approach is based on the over expression and unique role of developmental HOX genes in tumour biology and pathogenesis. The HOX genes offer a novel therapeutic target in cancer biology with potential applicability across many cancer types. Largely silenced just after birth, aberrant HOX gene expression has been shown to have pro-oncogenic effects. There is increasing recognition that re-activation of HOX genes is involved in the pathogenesis of common cancers. HOX proteins bind to DNA in combination with a co-factor, Pre-B-cell Leukaemia Homeobox (PBX). The Company was founded by world leading experts in HOX gene family biology and clinical oncology, Professor Hardev Pandha, Head of Oncology, University of Surrey and Professor Richard Morgan, Institute of Cancer Therapeutics, Bradford. The Company is initially focused on novel treatments for brain and prostate cancer.

Xuzhou Cell Medical Co., Ltd., established on 2017-06-22, The business scope includes research and development of stem cell and immune cell therapy technology,Clinical Research and Clinical Translation;Development and production of cellular medicines;storage of cells and tissues;technology development in biotechnology,technology transfer,technical consulting,Technical Services;Research and development of biological products,production and sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Guangzhou Saiao Biotechnology Co., Ltd., established on 2015-01-26, Business scope includes technical services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Human stem cell technology development and application;R&D and application of cell technology;

Shandong Sukahan Bio Technology Co., Ltd. principally engages in the research, development, production, and sale of enzyme-bacterial biological preparations and bio-organic fertilizers. The company was founded by Wei Hua Han on February 18, 2004 and is headquartered in Weifang, China.

Chongqing Saiao Biotechnology Co., Ltd., established on 2014-11-28, Business scope includes general items:stem cell biotechnology(Except for special items),immune cell biotechnology,Technology development in the field of laboratory equipment technology,technical consulting,Technical Services,technology transfer;Cell Preparation and Storage Services(Except for special regulations of the state);Sales of chemical products and raw materials(Free of hazardous chemicals and precursor chemicals).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Beijing Saiao Biotechnology Co., Ltd., established on 2013-07-18, Business scope includes stem cell and immune cell therapy technology,Laboratory Equipment Technology,Biotechnology,Technology development in the field of cell preparation and storage services,technology transfer,technical consulting,Technical Services;health management,Health Advisory(Except for medical treatment activities subject to approval);Sales of chemical products(Free of Hazardous Chemicals),cosmetic,medical instruments(I,IIkind);medical service.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Medical services and items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

iCell is a cell biotechnology company that specializes in basic research and clinical applications of immune cells. The company focuses on stem cell and immune cell basic research and clinical translational application research, cell product development, production and quality assurance, preclinical cell therapy testing, clinical efficacy evaluation and prognostic analysis, and providing cell therapy to doctors and patients.

Beijing Jingshuo Zhongbang Medical Technology Co., Ltd., established on 2015-04-30, Business scope includes technology development,Technical Services,technical consulting;Conference Services;Undertake exhibition and display activities;sell electronics,computer,Software and Auxiliary Equipment,hardware,AC,building materials,Equipment,medical instrumentsIkind,IIkind;Engineering survey and design;Repair medical equipment and equipment;Medical equipment rental;sell food;Sales of Class III Medical Devices(Market entities independently choose business projects in accordance with the law,Carry out business activities;Sales of Class III Medical Devices;sell food.and items that are legally subject to approval,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Hunan Hongying Biotechnology Co., Ltd., a subsidiary of Guangdong Vtr Bio-Tech Co., Ltd., is a company headquartered in Changde, China. The firm manufactures, develops and wholesales biological products. It was founded in 2011. Hunan Hongying Biotechnology Co., Ltd. was acquired by Guangdong Vtr Bio-Tech Co., Ltd. on December 29, 2014 for $43.56 million.

Sichuan Guoke Zhongnong Biotechnology Co., Ltd., established on 2010-04-08, Business scope includes production,Sales,Commissioned processing:Microbial fertilizer,organic fertilizer,organic-Inorganic Compound Fertilizer,Water soluble fertilizer(The above two items are limited to branch operations);Sales:fertilizer,distiller's grains;Agricultural Technology Development,consultation service;Self-operated and agent import and export business of various commodities and technologies(Except for goods that are restricted or prohibited from import and export by the state).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Qianhe Condiment & Food Co., Ltd. engages in the research and development, production and sales of food additives and condiments. Its condiments include seasonings, soy sauce, vinegar, and cooking wine. The company was founded by Chao Qun Wu on January 31, 1996 and is headquartered in Meishan, China.

Yunnan Concentrator Technology Co., Ltd., established on 2015-12-22, Business scope includes computer software and hardware,Communication equipment,electronic product,energy saving equipment,Green facilities,Instrumentation,security equipment,building materials,Research on decorative materials,Development and Sales;construction work,River and lake improvement project,Environmental Engineering,Municipal Engineering Consulting,Design and Construction;Environmental pollution control and facility operation;Environmental Engineering Supervision,monitor,detection,Evaluate;Non-ferrous metal smelting waste,organic waste,Collection of Pharmaceutical Waste,save,use;Project investment and management of invested projects.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shanghai Lanhai Biotechnology Co., Ltd., established on 2009-10-21, The scope of business includes engaging in technology development in the field of biotechnology,technology transfer,technical consulting,Technical Services,Chemical Products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals),cosmetic,crafts(Except for ivory and its products),home decoration,Clothing,food additives,Sales of daily necessities,food sales. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Beijing Zhongtai Henderson Biotechnology Co., Ltd., established on 2011-05-13, Business scope includes technology development,technology transfer,technical consulting,Technical Services,Technology Promotion;Educational Consulting;sell cosmetics,self-developed product,Chemical Products(Does not contain dangerous chemicals and a class of precursor chemicals),daily necessities,electronic product,Equipment,Instrumentation,computer,Software and Auxiliary Equipment,medical instrumentsIkind;Office Equipment Repair;Technology Import and Export,Import and export,Agent import and export.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Lance Cell Biotechnology (Guangzhou) Co., Ltd., established on 2017-09-14, The business scope includes the development and application of human stem cell technology;R&D and application of cell technology;Development of Human Gene Diagnosis and Therapy Technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Biomass Energy Technology Services;Biochemical product technology research and development;New material technology research and development;3Dprint service;Food Internet Sales(Only sell prepackaged food);food business(Only sell prepackaged food);Sales of Class I Medical Devices;Sales of Class II Medical Devices;Sales of hygiene products and single-use medical products;Health Care Services(non-medical);Traditional Chinese Medicine Health Care Services(non-medical);Nursing facility services(Does not include medical services);Remote Health Management Services;Health Consulting Services(Does not include medical services);Sports Health Service;Medical Research and Experimental Development;Engage in investment activities with own funds;Domestic trade agent;trade broker;Information Technology Consulting Services;Cosmetics Wholesale;Cosmetics Retail;Sales of electrical machinery and equipment;Sales of electronic special equipment;electronics sales;Instrument sales;Optical Instrument Sales;internet sales(Except for products that require a license for sale);Personal Internet Live Streaming Service(Need to record);Sales of electronic measuring instruments;Sales of electrical instruments and meters;Wholesale of electronic components;Production of hygiene products and single-use medical products;Health food sales;Class III medical device business;Internet Information Service for Medical Devices;Import and export;liquor business;Inspection and testing service;Internet hospital services relying on physical hospitals

Wuxi Zhongshun Biotechnology Co., Ltd., established on 2000-08-04, Business scope includes licensed projects:feed production;Feed additive production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Animal Husbandry and Fishery Feed Sales;Feed Additive Sales;Specialty Chemicals Sales(Free of Hazardous Chemicals);Fishing Machinery Sales;Sales of special instruments and meters for environmental monitoring;Aquatic product retail(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Beijing Cellonis Gene Biotechnology Co., Ltd. engages in the research and development of customized cells technology. Its service platform includes stem cells, immune cells, and cell storage. Its products and services include placenta and umbilical cord stem cells, immune cells, fibroblasts, storage opportunity, collection and transportation, cell preparation, cell cryopreservation, disease treatment, sub-health conditioning, 360 tumor warning, immune training, specialized center for cell-based therapy rejuvenation, and cell customization. The company was founded in 2004 and is headquartered in Beijing, China.